Elixir Medical's first first-in-man study of a low-dose myolimus-eluting coronary stent.
Phase of Trial: Phase I
Latest Information Update: 18 May 2012
At a glance
- Drugs Myolimus (Primary)
- Indications Coronary artery disease; Coronary artery restenosis; Various toxicities
- Focus Adverse reactions; Therapeutic Use
- 18 May 2012 New trial record